COVID – 19 Infection: Origin, epidemiology, and clinical features of human coronavirus

Abstract

Background: With the onset and spread of the 2019 novel coronavirus (2019-nCoV), a new public health disaster threatened the world. In December 2019, the virus was suggested to have originated from bats and had been transmitted to humans via unidentified intermediary species in Wuhan, Hubei Province, China. There have been about 469, 212, 705 confirmed cases across the globe with about 6, 077, 255 reported deaths as of 03/18/2022. Infection is contracted by inhaling droplets or touching infected surfaces and introducing pick-up viruses to the nose, mouth, and eyes. The coronavirus incubation time is currently believed to be between two and fourteen days after exposure, and the infection can cause the severity of illness, including the death of the patient. Methods: The study employed a narrative review method to investigate literature and establish the current status of coronavirus and the most effective measures in curbing its infection rate and management of infected persons. Results: The study revealed that Vitamin C, hydroxychloroquine, antibiotics, and antivirals such as remdesivir and sotrovimab are treatment remedies used in proven instances. At home, adequate ventilation and sunlight are suggested to facilitate the reduction in exposure to SARS-CoV-2. Other prevention strategies include rooms, surfaces, and equipment with regular decontamination preferably with sodium hypochlorite, Individuals are encouraged to take the COVID-19 vaccine. Conclusion: Various measures outlined in this study have proven to decrease the spread of SARS-CoV-2 in Ghana, with the global consequences of this new disease still being explored.